206 related articles for article (PubMed ID: 27295529)
1. Future Directions in the Biology of Neuroendocrine Tumors.
Halperin DM; Dasari A; Yao JC
Pancreas; 2016 Jul; 45(6):783-5. PubMed ID: 27295529
[TBL] [Abstract][Full Text] [Related]
2. Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors.
Asa SL; La Rosa S; Basturk O; Adsay V; Minnetti M; Grossman AB
Endocr Pathol; 2021 Mar; 32(1):169-191. PubMed ID: 33459926
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic aspects on therapy development for gastroenteropancreatic neuroendocrine tumors.
Larsson C
Neuroendocrinology; 2013; 97(1):19-25. PubMed ID: 22456267
[TBL] [Abstract][Full Text] [Related]
4. Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines.
Boora GK; Kanwar R; Kulkarni AA; Pleticha J; Ames M; Schroth G; Beutler AS; Banck MS
Cancer Genet; 2015; 208(7-8):374-81. PubMed ID: 26087898
[TBL] [Abstract][Full Text] [Related]
5. Genetics of pancreatic neuroendocrine tumors: implications for the clinic.
Pea A; Hruban RH; Wood LD
Expert Rev Gastroenterol Hepatol; 2015; 9(11):1407-19. PubMed ID: 26413978
[TBL] [Abstract][Full Text] [Related]
6. Application of multiomics sequencing and advances in the molecular mechanisms of pancreatic neuroendocrine neoplasms.
Jiang R; Hong X; Zhao Y; Wu W
Cancer Lett; 2021 Feb; 499():39-48. PubMed ID: 33246093
[TBL] [Abstract][Full Text] [Related]
7. Gastroenteropancreatic endocrine tumors.
Meeker A; Heaphy C
Mol Cell Endocrinol; 2014 Apr; 386(1-2):101-20. PubMed ID: 23906538
[TBL] [Abstract][Full Text] [Related]
8. Molecular and Cell Biological Aspects of Gastroenteropancreatic Neuroendocrine Tumor Disease. Conference proceedings. Berlin, Germany, November 3-7, 1993.
Ann N Y Acad Sci; 1994 Sep; 733():1-535. PubMed ID: 7978857
[No Abstract] [Full Text] [Related]
9. Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors.
Rindi G; Villanacci V; Ubiali A
Digestion; 2000; 62 Suppl 1():19-26. PubMed ID: 10940683
[TBL] [Abstract][Full Text] [Related]
10. Site-Specific Genomic Alterations in a Well-Differentiated Pancreatic Neuroendocrine Tumor With High-Grade Progression.
Martin DR; LaBauve E; Pomo JM; Chiu VK; Hanson JA; Gullapalli RR
Pancreas; 2018 Apr; 47(4):502-510. PubMed ID: 29521944
[TBL] [Abstract][Full Text] [Related]
11. An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology.
Chetty R
Arch Pathol Lab Med; 2008 Aug; 132(8):1285-9. PubMed ID: 18684027
[TBL] [Abstract][Full Text] [Related]
12. Molecular aspects of the endocrine tumours of the pancreas and the gastrointestinal tract.
Rindi G; Candusso ME; Solcia E
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S135-8. PubMed ID: 10604117
[TBL] [Abstract][Full Text] [Related]
13. Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system.
Arnold CN; Sosnowski A; Schmitt-Gräff A; Arnold R; Blum HE
Int J Cancer; 2007 May; 120(10):2157-64. PubMed ID: 17278096
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroenteropancreatic tumors.
Lubomierski N; Kersting M; Bert T; Muench K; Wulbrand U; Schuermann M; Bartsch D; Simon B
Cancer Res; 2001 Aug; 61(15):5905-10. PubMed ID: 11479232
[TBL] [Abstract][Full Text] [Related]
15. The p53 network as therapeutic target in gastroenteropancreatic neuroendocrine neoplasms.
Briest F; Grabowski P
Cancer Treat Rev; 2015 May; 41(5):423-30. PubMed ID: 25837868
[TBL] [Abstract][Full Text] [Related]
16. Site- and grade-specific diversity of LINE1 methylation pattern in gastroenteropancreatic neuroendocrine tumours.
Stricker I; Tzivras D; Nambiar S; Wulf J; Liffers ST; Vogt M; Verdoodt B; Tannapfel A; Mirmohammadsadegh A
Anticancer Res; 2012 Sep; 32(9):3699-706. PubMed ID: 22993308
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic changes in gastroenteropancreatic neuroendocrine tumours.
Mapelli P; Aboagye EO; Stebbing J; Sharma R
Oncogene; 2015 Aug; 34(34):4439-47. PubMed ID: 25435371
[TBL] [Abstract][Full Text] [Related]
18. Genomic landscape of pancreatic neuroendocrine tumors.
Gebauer N; Schmidt-Werthern C; Bernard V; Feller AC; Keck T; Begum N; Rades D; Lehnert H; Brabant G; Thorns C
World J Gastroenterol; 2014 Dec; 20(46):17498-506. PubMed ID: 25516664
[TBL] [Abstract][Full Text] [Related]
19. Differential methylation of G-protein coupled receptor signaling genes in gastrointestinal neuroendocrine tumors.
Byun S; Affolter KE; Snow AK; Curtin K; Cannon AR; Cannon-Albright LA; Thota R; Neklason DW
Sci Rep; 2021 Jun; 11(1):12303. PubMed ID: 34112938
[TBL] [Abstract][Full Text] [Related]
20. Expression of growth factors and their receptors in neuroendocrine gut and pancreatic tumors, and prognostic factors for survival.
Oberg K
Ann N Y Acad Sci; 1994 Sep; 733():46-55. PubMed ID: 7978895
[No Abstract] [Full Text] [Related]
[Next] [New Search]
